Sheath seat with built-in hemostasis valve structure and catheter sheath

By incorporating a hemostatic valve structure within the catheter sheath seat, a sealed and low-friction process is achieved during the withdrawal of the dilator and medical devices, solving the problems of blood reflux and friction damage, and reducing the risk of infection.

CN119015570APending Publication Date: 2024-11-26WEICAN (NANJING) MEDICAL TECH DEV CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410884222.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-03
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing catheter sheaths are prone to causing blood reflux and friction damage during the removal of dilators and medical devices, increasing the risk of infection.

Method used

A sheath seat with a built-in hemostatic valve structure was designed, comprising a sheath seat body and a hemostatic valve. The hemostatic valve remains sealed when the dilator or sheath is punctured or removed, reducing blood backflow, and friction is reduced by providing a cavity inside the hemostatic valve.

Benefits of technology

It effectively avoids blood reflux and friction damage during the removal of dilators and medical devices, reducing the risk of infection and device damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015570A_ABST
    Figure CN119015570A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical instruments, in particular to a sheath base and a catheter sheath with a built-in hemostasis valve structure, a sheath base body is provided with a containing cavity used for containing a hemostasis valve, a cavity is formed in the center of the hemostasis valve, and a drift diameter is preset in the central axis direction of the sheath base body; a dilator or a sheath tube can penetrate through the hemostasis valve along the drift diameter, and the hemostasis valve can seal the sheath base in the dilator or sheath tube puncturing or removing state. According to the catheter sheath, the hemostasis valve is arranged in the sheath base, blood backflow possibly occurring in the process of withdrawing the dilator and the medical instrument through the catheter sheath is avoided, and meanwhile, the cavity is formed in the hemostasis valve, so that friction occurring in the process of withdrawing the dilator and the medical instrument is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of medical devices, and in particular to a sheath seat and a catheter sheath with a built-in hemostatic valve structure. Background Art

[0002] The catheter sheath is an important auxiliary guiding device for peripheral and intracardiac minimally invasive interventional surgery. It is used to establish a connection channel between human blood vessels and the outside world during interventional surgeries such as thrombectomy, percutaneous coronary intervention, and percutaneous interventional occlusion, thereby assisting the delivery tube to deliver diagnostic and treatment equipment to the lesion site. The catheter sheath commonly used in interventional treatment is currently composed of a sheath seat and a dilator. During use, the catheter sheath is first inserted into the human blood vessel using the dilator and guidewire, and then the dilator is withdrawn, and the medical device to be inserted, such as a catheter, is delivered from the sheath into the human blood vessel. After use, the medical device can be withdrawn from the sheath from the human blood vessel, and then the sheath seat can be twisted off, and the sheath can be torn open and completely withdrawn from the body, which provides convenience for the intubation process and reduces damage to the blood vessels. It is suitable for a variety of interventional surgical operations.

[0003] During the process of withdrawing the dilator and medical device, blood reflux may occur, which may lead to an increased risk of infection and bleeding and hematoma. At the same time, the hemostatic valve in the prior art may rub during the process of withdrawing the dilator and medical device, which may cause damage to the dilator and medical device. Summary of the invention

[0004] In response to the above technical problems, the present application provides a sheath seat with a built-in hemostatic valve structure, including a sheath seat body and a hemostatic valve. The sheath seat body is provided with a accommodating cavity for accommodating the hemostatic valve. The central area of ​​the hemostatic valve is provided with a cavity. A through diameter is preset along the central axis direction of the sheath seat body. A dilator or sheath tube can penetrate the hemostatic valve along the through diameter. The hemostatic valve can seal the sheath seat when the dilator or sheath tube is punctured or removed.

[0005] Preferably, the hemostatic valve is a conical cylinder, which is composed of a cone and a cylinder, which is composed of a conical part and a cylindrical part, the connection between the bottom surface of the conical part and the top surface of the cylindrical part is a continuous surface, one end of the bottom surface of the cylindrical part of the conical cylinder is an embedded end, one end of the top angle of the conical part of the conical cylinder is a force-bearing end, and the hemostatic valve is embedded in the inner wall of the accommodating cavity of the sheath seat body through the embedded end.

[0006] Preferably, the inner wall of the sheath seat body is provided with a centrally symmetrical first groove a and a positioning protrusion b, and the embedded end of the hemostatic valve is provided with a centrally symmetrical positioning groove c and a first protrusion d, the first groove a and the first protrusion d cooperate with each other, and the positioning protrusion b and the positioning groove c cooperate with each other.

[0007] Preferably, the cavity is composed of at least one cavity section, and the central axes of the cavity section, the hemostatic valve and the sheath seat are collinear.

[0008] Preferably, the cavity section is a conical cylinder, and the conical cylindrical cavity section is composed of a conical part cavity section and a cylindrical part cavity section, and the connection between the bottom surface of the conical part cavity section and the top surface of the cylindrical part cavity section is a continuous surface.

[0009] Preferably, the conical cylindrical cavity is composed of at least two conical cylindrical cavity sections, the cone heads of the conical cylindrical cavity sections face the force-bearing ends, and the conical cylindrical cavity sections are connected end to end.

[0010] Preferably, the volume of the cavity does not exceed 48.6% of the volume of the hemostatic valve.

[0011] Preferably, the hemostatic valve is made of silicone.

[0012] Preferably, the vertex angle of the cone portion of the hemostatic valve is between 90° and 180°.

[0013] According to a second aspect of one or more embodiments of the present application, a catheter sheath is provided, wherein the catheter sheath uses an optional sheath seat with the built-in hemostatic valve structure.

[0014] The present application avoids possible blood backflow during the withdrawal of the dilator and the medical device through the catheter sheath by building a hemostatic valve into the sheath seat, and reduces friction during the withdrawal of the dilator and the medical device by providing a cavity in the hemostatic valve. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] The present application is further described below in conjunction with the accompanying drawings.

[0016] Figure 1 A schematic cross-sectional view of a sheath seat of a built-in hemostatic valve structure according to an exemplary embodiment of the present application;

[0017] Figure 2 A schematic cross-sectional view of a sheath seat of a built-in hemostatic valve structure according to another exemplary embodiment of the present application;

[0018] Figure 3 A schematic cross-sectional view of a sheath seat of a built-in hemostatic valve structure according to another exemplary embodiment of the present application;

[0019] Figure 4 This is a schematic diagram of the relationship between cavity volume ratio, friction force and pressure resistance of an exemplary embodiment of the present application.

[0020] The numbers in the figure represent:

[0021] 1-sheath seat body, 2-hemostatic valve, 21-through diameter, 22-cavity, 221-first cavity section, 222-second cavity section. DETAILED DESCRIPTION

[0022] The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present application.

[0023] In the description of the present application, it should be understood that the directions or positional relationships indicated by the terms "front", "rear", "left", "right", "up", "down", etc. are based on the directions or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore should not be understood as a limitation on the present application.

[0024] like Figure 1-4 As shown, the present application provides a sheath seat with a built-in hemostatic valve structure, comprising:

[0025] The present application provides a sheath seat with a built-in hemostatic valve structure, including a sheath seat body 1 and a hemostatic valve 2. The sheath seat body 1 is provided with a accommodating cavity 11 for accommodating the hemostatic valve 2, and a cavity 22 is provided in the central area of ​​the hemostatic valve 2. A through diameter 21 is preset along the central axis direction of the sheath seat body 1. A dilator or sheath tube can penetrate the hemostatic valve 2 along the through diameter 21. The hemostatic valve 2 can seal the sheath seat when the dilator or sheath tube is punctured or removed.

[0026] When the sheath seat with a built-in hemostatic valve structure provided by the present application is used for working with a catheter sheath, the medical staff holds the sheath seat body 1 and inserts the dilator into the sheath seat body 1 according to a predetermined path, i.e., the diameter 21. At this time, the dilator passes through the hemostatic valve 2, and the hemostatic valve 2 has self-tightness, i.e., the hemostatic valve 2 has the characteristic of being able to automatically flow and fill into irregular surfaces or gaps, and finally forming a smooth and uniform surface after being stationary. This characteristic makes the contact point between the dilator and the hemostatic valve 2 sealed to avoid liquid leakage or infection. After the dilator completes the puncture, the dilator and the guide wire are withdrawn, and then the corresponding medical device is introduced through the sheath. After the medical device is placed, the connection with the external processing working environment can be opened by rotating the three-way valve, and contrast agent or saline or other drugs can be injected. After the operation is completed, the three-way valve is rotated to close and externally processed, and the medical device is withdrawn through the sheath. The medical device passes through the hemostatic valve 2. The self-tightness of the hemostatic valve 2 makes the withdrawal channel of the medical device automatically closed after withdrawal, preventing blood reflux and avoiding the risk of infection caused by body fluids being brought out of the catheter sheath by the medical device. When the medical device passes through the hemostatic valve 2 and is withdrawn, the cavity 22 in the hemostatic valve 2 reduces the friction between the medical device and the hemostatic valve 2, avoiding the medical staff from twisting and damaging the medical device when withdrawing. After the medical device is withdrawn, the sheath seat body 1 is twisted off, and then the sheath is torn open and withdrawn from the broken position. Therefore, the present application avoids the possible blood reflux that may occur during the withdrawal of the dilator and medical device through the catheter sheath by building a hemostatic valve 2 into the accommodating cavity 11 of the sheath seat body 1. At the same time, by providing a cavity 22 in the hemostatic valve 2, the friction that occurs during the withdrawal of the dilator and catheter or other medical devices can be reduced. Theoretically, the larger the volume of the cavity 22, the smaller the friction resistance of the sheath and the dilator tube to enter or exit

[0027] In a specific embodiment, if Figure 1-4As shown, the hemostatic valve 2 is a conical cylinder, which is composed of a conical part and a cylindrical part. The connection between the bottom surface of the conical part and the top surface of the cylindrical part is a continuous surface. One end of the bottom surface of the cylindrical part of the conical cylinder is an embedding end, and one end of the top angle of the conical part of the conical cylinder is a force-bearing end. The hemostatic valve 2 is embedded in the inner wall of the accommodating cavity 11 of the sheath seat body 1 through the embedding end. The embedding end of the conical cylinder of the hemostatic valve 2 is the bottom surface of the cylindrical part. The bottom surface diameter of the conical part of the hemostatic valve 2 is appropriately greater than the diameter inside the accommodating cavity 11. The hemostatic valve 2 is made of soft material and can be squeezed and embedded in the inner wall of the accommodating cavity 11 of the sheath seat body 1, thereby forming a seal. When the hemostatic valve 2 is inserted into the accommodating cavity 11 during assembly, the side of the cylindrical part will fit the side wall of the accommodating cavity 11 of the sheath seat body 1, preventing body fluids from flowing out of the gap between the hemostatic valve 2 and the sheath seat body 1. One end of the apex angle of the cone portion of the hemostatic valve 2 is the force-bearing end. When the medical device is withdrawn, the conical outer surface is the force-bearing surface, and the body fluid is blocked on the cone outer surface, thereby preventing the body fluid from flowing back.

[0028] In a specific embodiment, if Figure 1-3As shown, the inner wall of the sheath seat body 1 is provided with a centrally symmetrical first groove a and a positioning protrusion b, and the embedded end of the hemostatic valve 2 is provided with a centrally symmetrical positioning groove c and a first protrusion d, the first groove a and the first protrusion d are respectively located on the side wall of the accommodating cavity 11 of the sheath tube body 1 and the side of the embedded end of the hemostatic valve 2, the first groove a and the first protrusion d cooperate to limit the movement of the hemostatic valve 2 in the horizontal direction, the positioning protrusion b and the positioning groove c are respectively located on the front wall of the accommodating cavity 11 of the sheath tube body 1 and the top surface of the embedded end of the hemostatic valve 2, the positioning protrusion b and the positioning groove c cooperate to limit the movement of the hemostatic valve 2 in the vertical direction, the two cooperate to make the hemostatic valve 2 firmly embedded in the accommodating cavity 11 of the sheath seat body 1, and it will not move toward the sheath direction under the action of friction when the medical device is inserted, nor will it move in the vertical direction to cause the center axis to shift. In another specific embodiment, the inner wall of the sheath seat body 1 is provided with a centrally symmetrical positioning groove g and a second protrusion h, and the embedded end of the hemostatic valve 2 is provided with a centrally symmetrical positioning protrusion i and a second groove j, the second protrusion h and the second groove j are respectively located on the side wall of the accommodating cavity 11 of the sheath body 1 and the side of the embedded end of the hemostatic valve 2, the second protrusion h and the second groove j cooperate to limit the movement of the hemostatic valve 2 in the horizontal direction, the positioning groove g and the positioning protrusion i are respectively located on the front wall of the accommodating cavity 11 of the sheath body 1 and the top surface of the embedded end of the hemostatic valve 2, the positioning groove g and the positioning protrusion i cooperate to limit the movement of the hemostatic valve 2 in the vertical direction, and the cooperation of the two makes the hemostatic valve 2 firmly embedded in the accommodating cavity 11 of the sheath seat body 1. There can also be other mortise and tenon structures that can achieve the above-mentioned effects, and this application does not limit this.

[0029] In a specific embodiment, the cavity 22 is composed of at least one cavity section, and the central axes of the cavity section, the hemostatic valve 2 and the sheath seat 1 are collinear. Figure 1 As shown, the cavity 22 includes a cavity section, and the cavity section is in the shape of a conical cylinder; Figure 2 As shown, the cavity 22 includes two cavity sections, specifically a first cavity section 221 and a second cavity section 222. The first cavity section 221 and the second cavity section 222 are both conical cylinders. Figure 3 As shown, the cavity 22 includes three cavity divisions. On the basis of maintaining the pressure resistance and sealing performance of the hemostatic valve 2, the width of the cavity 22 should be as large as possible to minimize the friction between the medical device / sheath tube / dilator tube and the hemostatic valve 2 when entering or exiting the hemostatic valve 2. The central axes of the cavity divisions, the hemostatic valve 2 and the sheath seat 1 are collinear to facilitate rapid and accurate insertion and removal of medical devices.

[0030] In a specific embodiment, the cavity section is a conical cylinder, and the conical cylindrical cavity section is composed of a conical cavity section and a cylindrical cavity section, and the connection between the bottom surface of the conical cavity section and the top surface of the cylindrical cavity section is a continuous surface. In a specific embodiment, the conical cylindrical cavity is composed of at least two conical cylindrical cavity sections, and the cone head of the conical cylindrical cavity section faces the force-bearing end, and the conical cylindrical cavity sections are connected end to end. Figure 2-3 As shown, the cone heads of the multiple conical cylindrical cavity divisions face the force-bearing end, and the hemostatic valve 2 body between the cavity divisions plays a role in blocking the backflow of liquid in sections, such as Figure 2 As shown, even if liquid is brought into the first cavity section 221 when the medical device is withdrawn from the sheath, because the passage 21 left by the cone head of the second cavity section 222 is narrow and self-tight, the liquid is easily blocked by the spacer between the first cavity section 221 and the second cavity section 222 and cannot enter the second cavity section 222. Compared with one cavity section, the hemostatic effect can be further improved.

[0031] In a specific embodiment, the volume of the cavity 22 does not exceed 48.6% of the volume of the hemostatic valve 2. Figure 4 As shown, the larger the volume proportion of the cavity 22, the smaller the friction resistance of the sheath and the dilation tube entering or exiting the hemostatic valve 2. The hemostatic valve 2 used in the test is a conical cylinder, which is composed of a conical part and a cylindrical part. The connection between the bottom surface of the conical part and the top surface of the cylindrical part is a continuous surface. The diameter of the cylindrical part is 10 mm, and the length along the central axis direction of the sheath seat body 1 is 5 mm. When there is no cavity 22 at all, the friction resistance is the largest, with an average value of 5.09N. When it is completely penetrated, that is, when the volume proportion of the cavity 22 is 100%, there is no resistance to the penetration of the instrument. However, the increase in the volume proportion of the cavity 22 will cause the pressure resistance value of the entire system to decrease. This application uses the system leakage at 300kpa for 20s as the detection standard, that is, if there is no leakage in the system within 20s at 300kpa, it is considered to be qualified for the pressure resistance test, otherwise it is unqualified. Figure 4 As shown, when the volume proportion of the cavity 22 increases to 48.6%, the withstand voltage test fails.

[0032] On the basis of passing the pressure test, the volume proportion of the cavity 22 should be increased as much as possible to reduce friction resistance. When the hemostatic valve 2 is a conical body, and the diameter of the cylindrical part is 10mm, and the length along the central axis direction of the sheath seat body 1 is 5mm, the cavity 22 can be composed of a conical cylindrical cavity section. At this time, the optimal size of the conical cylindrical cavity section is: OD=8mm, L=3mm, OD is the outer diameter of the cylindrical part of the cavity section, and L is the length along the central axis direction of the sheath seat body 1; the cavity 22 can be composed of 2 conical cylindrical cavity sections. At this time, the optimal size of the conical cylindrical cavity section is: OD=7mm, L=2mm; the cavity 22 can also be composed of 3 conical cylindrical cavity sections. At this time, the optimal size of the conical cylindrical cavity section is: OD=9mm, L=1mm; the cavity 22 can also be composed of 4 conical cylindrical cavity sections. At this time, the optimal size of the conical cylindrical cavity section is: OD<8mm, L=1mm.

[0033] In another specific embodiment, the bottom diameters of the conical parts of the plurality of conical cylindrical cavity sections increase in sequence from the cone head close to the hemostatic valve 2 to the cone head far away from the hemostatic valve 2 .

[0034] In another specific embodiment, the cavity 22 is composed of at least one conical cavity section, and the central axes of the conical cavity section, the hemostatic valve 2 and the sheath seat 1 are collinear. In the case where the cavity 22 is composed of two conical cavity sections, the cone head of the conical cavity section faces the force-bearing end, and the conical cavities are connected end to end. The total volume of the conical cavity section does not exceed 48.6% of the volume of the hemostatic valve 2. In another specific embodiment, the bottom diameters of the multiple conical cavity sections are arranged in order from the cone head close to the hemostatic valve 2 to the cone head away from the hemostatic valve 2.

[0035] In a specific embodiment, the hemostatic valve 2 is made of silicone. The silicone material has a very dense structure and can effectively prevent the penetration of external substances such as water, air and microorganisms, thereby achieving a good sealing effect, that is, strong self-tightness. At the same time, silicone is also a very soft material that can maintain its elasticity and softness under different temperatures and environments, which allows the silicone material to flexibly adapt to objects of various shapes and sizes. The silicone material also has good high temperature resistance and can operate stably for a long time under high temperature environments. The materials that also have self-tightness and softness include: fluororubber (FKM): fluororubber is a high-performance rubber with excellent self-tightness and chemical stability. It can be used for a long time under high temperature, high pressure and corrosive environments. Ethylene-Propylenol rubber (EPDM): EPDM is a synthetic rubber with good self-tightness and weather resistance. Butyl rubber (NBR): Butyl rubber is a general-purpose rubber with good oil resistance and heat resistance. The present application does not impose specific restrictions on the materials of the hemostatic valve 2 and the sheath body 1, as long as they meet the conditions of high self-tightness, high softness and non-toxicity.

[0036] In a specific embodiment, the vertex angle of the cone portion of the hemostatic valve 2 is between 90° and 180°. The side of the blunt-angle cone is relatively gentle, does not have the sharp feature of the acute-angle cone, and is relatively stable.

[0037] The present application also provides a catheter sheath, which uses the sheath seat with a built-in hemostatic valve structure in the above specific embodiment.

[0038] Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present application.

Claims

1. A sheath seat with a built-in hemostatic valve structure, characterized in that: The invention comprises a sheath seat body (1) and a hemostatic valve (2), wherein the sheath seat body (1) is provided with a housing cavity (11) for accommodating the hemostatic valve (2), a central area of ​​the hemostatic valve (2) is provided with a cavity (22), a through diameter (21) is preset along the central axis direction of the sheath seat body (1), a dilator or sheath tube can penetrate the hemostatic valve (2) along the through diameter (21), and the hemostatic valve (2) can seal the sheath seat when the dilator or sheath tube is punctured or removed.

2. The sheath seat with a built-in hemostatic valve structure according to claim 1, characterized in that: The hemostatic valve (2) is a conical cylinder, which is composed of a conical part and a cylindrical part. The connection between the bottom surface of the conical part and the top surface of the cylindrical part is a continuous surface. One end of the bottom surface of the cylindrical part of the conical cylinder is an embedded end, and one end of the top angle of the conical part of the conical cylinder is a force-bearing end. The hemostatic valve (2) is embedded in the inner wall of the accommodating cavity (11) of the sheath seat body (1) through the embedded end.

3. The sheath seat with a built-in hemostatic valve structure according to claim 2, characterized in that: The inner wall of the sheath seat body (1) is provided with a centrally symmetrical first groove a and a positioning protrusion b, and the embedded end of the hemostatic valve (2) is provided with a centrally symmetrical positioning groove c and a first protrusion d, the first groove a and the first protrusion d cooperate with each other, and the positioning protrusion b and the positioning groove c cooperate with each other.

4. The sheath seat with a built-in hemostatic valve structure according to claim 3, characterized in that: The cavity (22) is composed of at least one cavity section, and the central axes of the cavity section, the hemostatic valve (2) and the sheath seat (1) are collinear.

5. The sheath seat with a built-in hemostatic valve structure according to claim 4, characterized in that: The cavity section is a conical cylinder, and the conical cylindrical cavity section is composed of a conical part cavity section and a cylindrical part cavity section, and the connection between the bottom surface of the conical part cavity section and the top surface of the cylindrical part cavity section is a continuous surface.

6. The sheath seat with a built-in hemostatic valve structure according to claim 4, characterized in that: The cavity (22) is composed of at least two conical cylindrical cavity sections, the cone heads of the conical cylindrical cavity sections face the force-bearing ends, and the conical cylindrical cavity sections are connected end to end.

7. The sheath seat with a built-in hemostatic valve structure according to claim 1, characterized in that: The volume of the cavity (22) does not exceed 48.6% of the volume of the hemostatic valve (2).

8. The sheath seat with a built-in hemostatic valve structure according to claim 1, characterized in that: The hemostatic valve (2) is made of silicone.

9. The sheath seat with a built-in hemostatic valve structure according to claim 2, characterized in that: The vertex angle of the cone portion of the hemostatic valve (2) is between 90° and 180°.

10. A catheter sheath, characterized in that: The catheter sheath uses the sheath seat with a built-in hemostatic valve structure as described in any one of claims 1 to 9.